CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert
Cancer Research and Treatment. 2021;53(2):457-470.   Published online 2020 October 7    DOI: https://doi.org/10.4143/crt.2020.585

Excel Download

Design and Synthesis of Quinazolinone Tagged Acridones as Cytotoxic Agents and Their Effects on EGFR Tyrosine Kinase
Archiv der Pharmazie. 2014;347(9):624-634   Crossref logo
Link1 Link2

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
Cancer Research and Treatment. 2021;53(2):457-470   Crossref logo
Link1 Link2 Link3

Microrna-144 Expression Overcomes Resistance to EGFR-Tyrosine Kinase Inhibitors in EGFR Mutant Lung Cancer Cells by Targeting Survivin
Chest. 2016;150(4):714A   Crossref logo
Link1 Link2

ALK Tyrosine Kinase Inhibitors in Drug Sensitization
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. 2019;45-52   Crossref logo
Link1 Link2

Novel Benzimidazole Analogs as Inhibitors of EGFR Tyrosine Kinase
Chemical Biology & Drug Design. 2012;80(4):625-630   Crossref logo
Link1

Effect of siRNAs targeting the EGFR T790M mutation in a non-small cell lung cancer cell line resistant to EGFR tyrosine kinase inhibitors and combination with various agents
Biochemical and Biophysical Research Communications. 2013;431(3):623-629   Crossref logo
Link1 Link2

Bruton's Tyrosine Kinase (BTK) Inhibitors as Sensitizing Agents for Cancer Chemotherapy
Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. 2019;109-124   Crossref logo
Link1 Link2

Radiofrequency Ablation with Continued EGFR Tyrosine Kinase Inhibitor Therapy Prolongs Disease Control in EGFR-Mutant Advanced Lung Cancers with Acquired Resistance to EGFR Tyrosine Kinase Inhibitors: Two Case Reports

OncoTargets and Therapy. 2020;Volume 13:6789-6793   Crossref logo
Link1 Link2

Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
Thoracic Cancer. 2018;9(8):1012-1017   Crossref logo
Link1 Link2

INCIDENCE OF HEPATITIS B REACTIVATION DURING EGFR TYROSINE KINASE INHIBITORS TREATMENT IN NON-SMALL-CELL LUNG CANCER PATIENTS
Respirology. 2018;23:291-291   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.